(CNN) — About 3.6 million Medicare enrollees may qualify for coverage of the anti-obesity drug Wegovy, according to a KFF analysis released Wednesday. But it could wind up costing Medicare

Related Keywords

Juliette Cubanski , Cable News Network Inc , Health Aetna , Drug Administration , Program On Medicare , Warner Bros , Novo Nordisk , Cnn , Discovery Company , Medicare Policy , News Network ,